Copper tripeptide and extracellular-matrix accumulation PUBMED PMID 8227353 Rat wound-chamber experiments reported increased measured extracellular-matrix accumulation after copper-tripeptide exposure
dose of IV carnitine Loading dose 100 mg/kg IV over 30 minutes (maximal dose of 6 grams)
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)
Jiang L, Hickman JH, Wang SJ, Gu W
has received research funding from Exact Sciences, Pentax Medical, Symple Surgical, Nine Point Medical and Medtronic and has served as a consultant for Medtronic, Symple Surgical and CSA Medical
Development 143:314